• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Jade Biosciences, Inc. - Common Stock (NQ:JBIO)

    25.38 +2.37 (+10.30%)
    Streaming Delayed Price Updated: 4:00 PM EDT, Apr 22, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 1,261,525
    Open 23.01
    Bid (Size) 11.00 (1,000)
    Ask (Size) 29.60 (100)
    Prev. Close 23.01
    Today's Range 23.01 - 26.33
    52wk Range 6.565 - 26.33
    Shares Outstanding 28,985,019
    Dividend Yield 9.46%
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    Jade Biosciences Appoints Edward R. Conner, M.D., as Chief Medical Officer
    From Jade Biosciences
    Via GlobeNewswire
    News headline image
    Jade Biosciences Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update
    From Jade Biosciences
    Via GlobeNewswire

    Performance

    YTD
    +79.2%
    +79.2%
    1 Month
    +82.7%
    +82.7%
    3 Month
    +59.2%
    +59.2%
    6 Month
    +163.0%
    +163.0%
    1 Year
    +150.3%
    +150.3%

    More News

    Read More
    News headline image
    Jade Biosciences to Participate in Upcoming Conferences
    From Jade Biosciences
    Via GlobeNewswire
    News headline image
    Jade Biosciences Outlines Key 2026 Objectives and Strategy to Advance Pipeline of Potentially Best-in-Class Monoclonal Antibodies Across Multiple Autoimmune Diseases Ahead of the 44th Annual J.P. Morgan Healthcare Conference
    From Jade Biosciences
    Via GlobeNewswire
    News headline image
    Jade Biosciences Announces $45 Million Private Placement
    From Jade Biosciences
    Via GlobeNewswire
    News headline image
    Jazz Pharmaceuticals, Sigma Lithium, Zymeworks And Other Big Stocks Moving Higher On Monday ↗
    Via Benzinga
    News headline image
    Jade Biosciences Reports Third Quarter 2025 Financial Results and Provides Corporate Update
    From Jade Biosciences
    Via GlobeNewswire
    News headline image
    Jade Biosciences Presents New Data Demonstrating a Favorable Preclinical Safety Profile of JADE101 and a Translational Analysis of APRIL Mediated Biomarker Responses at the American Society of Nephrology Kidney Week 2025
    From Jade Biosciences
    Via GlobeNewswire
    News headline image
    Jade Biosciences to Participate in Upcoming Conferences
    From Jade Biosciences
    Via GlobeNewswire
    News headline image
    Jade Biosciences Announces New Data Presentations for JADE101 at the American Society of Nephrology Kidney Week 2025
    From Jade Biosciences
    Via GlobeNewswire
    News headline image
    Jade Biosciences Announces JADE201, a Potentially Best-in-Class Half-Life Extended Afucosylated Anti-BAFF Receptor Monoclonal Antibody in Development for Autoimmune Diseases
    From Jade Biosciences
    Via GlobeNewswire
    News headline image
    Jade Biosciences Announces $135 Million Private Placement
    From Jade Biosciences
    Via GlobeNewswire
    News headline image
    12 Health Care Stocks Moving In Wednesday's After-Market Session ↗
    Via Benzinga
    News headline image
    Jade Biosciences Announces First Cohort Dosed in Phase 1 Healthy Volunteer Clinical Trial of JADE101, a Novel and Potentially Best-in-Class Anti-APRIL Monoclonal Antibody Being Evaluated for the Treatment of IgA Nephropathy
    From Jade Biosciences
    Via GlobeNewswire
    News headline image
    Jade Biosciences to Participate in Upcoming Conferences
    From Jade Biosciences
    Via GlobeNewswire
    News headline image
    Jade Biosciences Posts Wider Loss in Q2 ↗
    Via The Motley Fool
    News headline image
    Jade Biosciences Reports Second Quarter 2025 Financial Results and Provides Corporate Update
    From Jade Biosciences
    Via GlobeNewswire
    News headline image
    Abbott Laboratories Issues Weak Earnings Forecast, Joins MP Materials And Other Big Stocks Moving Lower In Thursday's Pre-Market Session ↗
    Via Benzinga
    News headline image
    12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗
    Via Benzinga
    News headline image
    Why Sarepta Therapeutics Shares Are Trading Higher By 34%; Here Are 20 Stocks Moving Premarket ↗
    Via Benzinga
    News headline image
    Jade Biosciences to Participate in Two Upcoming Investor Conferences
    From Jade Biosciences
    Via GlobeNewswire
    News headline image
    Jade Biosciences Appoints Brad Dahms as Chief Financial Officer
    From Jade Biosciences
    Via GlobeNewswire
    News headline image
    12 Health Care Stocks Moving In Monday's Pre-Market Session ↗
    Via Benzinga
    News headline image
    Jade Biosciences Presents JADE101 Preclinical Data at the 62nd European Renal Association Congress Demonstrating Potential for Best-in-Class Profile in IgA Nephropathy
    From Jade Biosciences
    Via GlobeNewswire
    News headline image
    Jade Biosciences to Present New Preclinical Data on JADE101 at the 62nd European Renal Association Congress
    From Jade Biosciences
    Via GlobeNewswire

    Frequently Asked Questions

    Is Jade Biosciences, Inc. - Common Stock publicly traded?
    Yes, Jade Biosciences, Inc. - Common Stock is publicly traded.
    What exchange does Jade Biosciences, Inc. - Common Stock trade on?
    Jade Biosciences, Inc. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Jade Biosciences, Inc. - Common Stock?
    The ticker symbol for Jade Biosciences, Inc. - Common Stock is JBIO on the Nasdaq Stock Market
    What is the current price of Jade Biosciences, Inc. - Common Stock?
    The current price of Jade Biosciences, Inc. - Common Stock is 25.38
    When was Jade Biosciences, Inc. - Common Stock last traded?
    The last trade of Jade Biosciences, Inc. - Common Stock was at 04/22/26 04:00 PM ET
    What is the market capitalization of Jade Biosciences, Inc. - Common Stock?
    The market capitalization of Jade Biosciences, Inc. - Common Stock is 735.64M
    How many shares of Jade Biosciences, Inc. - Common Stock are outstanding?
    Jade Biosciences, Inc. - Common Stock has 736M shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.